Recurrence of low back pain is common: a prospective inception cohort study

Tatiane da Silva, Kathryn Mills, Benjamin T Brown, Natasha Pocovi, Tarcisio de Campos, Christopher Maher, Mark J Hancock, Tatiane da Silva, Kathryn Mills, Benjamin T Brown, Natasha Pocovi, Tarcisio de Campos, Christopher Maher, Mark J Hancock

Abstract

Questions: How commonly and how quickly does low back pain reoccur in a cohort of people who have recently recovered from an episode of low back pain? What are the prognostic factors for a recurrence of low back pain?

Design: Prospective inception cohort study with monthly follow-up for 12 months.

Participants: A total of 250 patients who had recovered from an episode of low back pain within the last month.

Outcome measures: The primary outcome was days to recurrence of an episode of low back pain. Secondary outcomes were: days to recurrence of low back pain severe enough to limit activity moderately, and days to recurrence of low back pain for which healthcare was sought.

Results: Within 12 months after recovery, 69% (95% CI 62 to 74) of participants had a recurrence of an episode of low back pain, 40% (95% CI 33 to 46) had a recurrence of activity-limiting low back pain, and 41% (95% CI 34 to 46) had a recurrence of low back pain for which healthcare was sought. The median time to recurrence of an episode of low back pain was 139 days (95% CI 105 to 173). Frequent exposure to awkward postures, longer time sitting (> 5 hours per day), and more than two previous episodes were predictive of recurrence of an episode of low back pain within 12 months (p < 0.01).

Conclusion: Recurrence of low back pain is very common, with more than two-thirds of individuals having a recurrence within 12 months after recovery. Prognostic factors for a recurrence include exposure to awkward posture, longer time sitting, and more than two previous episodes.

Keywords: Cohort studies; Low back pain; Prognosis; Recurrence; Risk.

Copyright © 2019 Australian Physiotherapy Association. Published by Elsevier B.V. All rights reserved.

Source: PubMed

3
Subskrybuj